Brief: Motus GI Gets Israeli Health Ministry Approval For Commercial Sales Of Gen2 Pure-Vu System In Israel
07/04/2020 14:27
April 7 (Reuters) - Motus GI Holdings Inc MOTS.O :
* MOTUS GI RECEIVES APPROVAL FROM THE ISRAELI MINISTRY OF
HEALTH
TO INITIATE COMMERCIAL SALES OF ITS GEN2 PURE-VU® SYSTEM IN
ISRAEL
Source text for Eikon: ID:nGNXc44qQ8
Further company coverage: MOTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Motus GI Holdings
See all newsBrief: Motus GI Holdings Inc Continuing To Explore A Range Of Strategic And Financing Alternatives
Brief: Motus Gi Holdings Files Prospectus Related To Resale Of Up To 4.4 Million Shares Of Common Stock, By The Selling Stockholder
Brief: Motus GI Granted A U.S. Patent For Key Feature Embodied By The Pure-Vu System
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Motus Gi Holdings Says Prices Public Offering At $1.50 Per Share